Average Co-Inventor Count = 6.93
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (23 from 3,681 patents)
2. Roche Innovation Center Copenhagen A/s (2 from 46 patents)
3. The Scripps Research Institute (1 from 1,186 patents)
4. Bristol Meyers Squibb Company (1 from 41 patents)
24 patents:
1. 11713316 - Substituted naphthyridinone compounds useful as T cell activators
2. 11613554 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds
3. 11447775 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof
4. 11359197 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof
5. 11058767 - CAMK2D antisense oligonucleotides and uses thereof
6. 10954238 - Substituted naphthyridinone compounds useful as T cell activators
7. 10869934 - Antiproliferative compounds and conjugates made therefrom
8. 10669272 - Substituted naphthyridinone compounds useful as T cell activators
9. 10398783 - Antiproliferative compounds and conjugates made therefrom
10. 10112975 - Benzodiazepine dimers, conjugates thereof, and methods of making and using
11. 9822144 - Benzodiazepine dimers, conjugates thereof, and methods of making and using
12. 9822112 - Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using
13. 9796713 - Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
14. 9708323 - Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
15. 9676794 - Benzodiazepine dimers, conjugates thereof, and methods of making and using